BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Prognosis
5 results:

  • 1. Competitive Risk Model Nomogram to Predict prognosis in Patients Aged Over 65 Years with nonmetastatic Cervical cancer: A SEER Population-Based Study.
    Jiao S; Guo L; Da F; Gao Q; Ren Z; Wang J; Fu Q; Liu J
    Technol Cancer Res Treat; 2023; 22():15330338231164191. PubMed ID: 37078156
    [No Abstract]    [Full Text] [Related]  

  • 2. A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: A large multicenter study.
    Tang X; Guo C; Liu S; Guo J; Hua K; Qiu J
    Int J Gynaecol Obstet; 2021 Oct; 155(1):86-94. PubMed ID: 33587753
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk of Gynecologic cancer as Second versus First Primary cancer in Japan.
    Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
    Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas.
    Chen Q; Shi H; Lu W; Lu B
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():85-89. PubMed ID: 30245442
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Response rate and cell-cycle changes due to intra-arterial infusion chemotherapy with cisplatin and bleomycin for locally recurrent uterine cervical cancer.
    Kigawa J; Kanamori Y; Ishihara H; Minagawa Y; Iwamoto K; Terakawa N
    Am J Clin Oncol; 1992 Dec; 15(6):474-9. PubMed ID: 1280402
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.